Genetic mutations in human rectal cancers detected by targeted sequencing (Q38989186)

8 September 2017

Genetic mutations in human rectal cancers detected by targeted sequencing (English)

1 reference

8 September 2017

Jun Bai

1

1 reference

8 September 2017

Jinglong Gao

2

1 reference

8 September 2017

Zhijun Mao

3

1 reference

8 September 2017

Jianhua Wang

4

1 reference

8 September 2017

Jianhui Li

5

1 reference

8 September 2017

Wensheng Li

6

1 reference

8 September 2017

Yu Lei

7

1 reference

8 September 2017

Shuaishuai Li

8

1 reference

8 September 2017

Zhuo Wu

9

1 reference

8 September 2017

Chuanning Tang

10

1 reference

8 September 2017

Lindsey Jones

11

1 reference

8 September 2017

Hua Ye

12

1 reference

8 September 2017

Feng Lou

13

1 reference

8 September 2017

Zhiyuan Liu

14

1 reference

8 September 2017

Zhishou Dong

15

1 reference

8 September 2017

Baishuai Guo

16

1 reference

8 September 2017

Xue F Huang

17

1 reference

8 September 2017

Si-Yi Chen

18

1 reference

8 September 2017

Enke Zhang

19

1 reference

8 September 2017

2 July 2015

1 reference

Journal of Human Genetics

8 September 2017

1 reference

8 September 2017

60

1 reference

8 September 2017

10

1 reference

8 September 2017

589-596

1 reference

https://scigraph.springernature.com/pub.10.1038/jhg.2015.71

8 September 2017

0 references

cites work

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

21 January 2018

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

The genetics of hereditary colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Screening for Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Technical and implementation issues in using next-generation sequencing of cancers in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Field guide to next-generation DNA sequencers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Frequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by ion torrent DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

A map of human genome variation from population-scale sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

APC gene: database of germline and somatic mutations in human tumors and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Exploiting APC function as a novel cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Mechanisms of tumor suppression by the SCF(Fbw7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Blocking oncogenic Ras signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Class I PI3K in oncogenic cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Cancer-specific mutations in PIK3CA are oncogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Systematic identification of genomic markers of drug sensitivity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

SMAD4 levels and response to 5-fluorouracil in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Cytoplasmic functions of the tumour suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Shaping genetic alterations in human cancer: the p53 mutation paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

The genetics of the p53 pathway, apoptosis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Mechanisms of oncogenesis in colon versus rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

SMAD4 as a Prognostic Marker in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2015.71

Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients.

21 January 2018

1 reference

12 December 2020

Colorectal cancer screening

1 reference

12 December 2020

Hereditary colorectal cancer

1 reference

12 December 2020

Next-generation sequencing for cancer diagnostics: a practical perspective.

1 reference

12 December 2020

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

1 reference

12 December 2020

Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance

1 reference

12 December 2020

p53 point mutation and survival in colorectal cancer patients

1 reference

12 December 2020

PIK3CA mutation is predictive of poor survival in patients with colorectal cancer

1 reference

12 December 2020

FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.

1 reference

12 December 2020

A pathway-centric survey of somatic mutations in Chinese patients with colorectal carcinomas

1 reference

12 December 2020

Mutated PI 3-kinases: cancer targets on a silver platter.

1 reference

12 December 2020

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

12 December 2020

Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation

1 reference

12 December 2020

Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/JHG.2015.71

1 reference

8 September 2017

0 references

1 reference